| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/30/2008 | EP1948627A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 07/30/2008 | EP1948607A2 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 07/30/2008 | EP1948606A1 3, 5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 07/30/2008 | EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 07/30/2008 | EP1948597A1 Derivatives for modulation of ion channels |
| 07/30/2008 | EP1948238A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 07/30/2008 | EP1948222A1 Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin |
| 07/30/2008 | EP1948217A2 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 07/30/2008 | EP1948215A1 Inhibitors of parp activity and uses thereof |
| 07/30/2008 | EP1948192A2 Therapeutic uses of steroidal compounds |
| 07/30/2008 | EP1948172A1 Diaryl ureas for treating diabetic neuropathy |
| 07/30/2008 | EP1948166A1 Carbazole derivatives as functional 5-ht6 ligands |
| 07/30/2008 | EP1948162A1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production |
| 07/30/2008 | EP1948157A2 Compositions for treating dermatological and neurological disorders |
| 07/30/2008 | EP1948153A2 Treatment of symptoms of parkinson`s disease |
| 07/30/2008 | EP1948144A2 Diaryl urea for treating diabetic neuropathy |
| 07/30/2008 | EP1809297B1 Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 07/30/2008 | EP1761514B1 Novel tetracyclic tetrahydrofuran derivatives |
| 07/30/2008 | EP1713475B1 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 07/30/2008 | EP1583538B1 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1272187B1 Dopamine-d3 receptor ligands for the treatment of addiction |
| 07/30/2008 | EP1233966B1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| 07/30/2008 | EP1226170B1 Human chordin and polynucleotides encoding the same |
| 07/30/2008 | EP1059927B1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | EP0994728B1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 07/30/2008 | CN101233119A Novel heterocyclic nf-kb inhibitors |
| 07/30/2008 | CN101233113A Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation |
| 07/30/2008 | CN101232888A Treatment of amyotrophic lateral sclerosis with norethindrone and analogues |
| 07/30/2008 | CN101232822A Composition for reducing the risc of ethanol metabolism and alcohol induced neuropathy |
| 07/30/2008 | CN101230066A Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| 07/30/2008 | CN101230062A Muscarinic acetycholine receptor antagonists |
| 07/30/2008 | CN101230061A Muscarinic acetycholine receptor antagonists |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN101230033A New azabicycloalkane derivatives, preparing method and medicament combination containing the same |
| 07/30/2008 | CN101230016A Pregabalin derivatives as well as preparation method and use thereof in treating neuropathic pain |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229370A Autologous T-cell vaccines against multiple sclerosis |
| 07/30/2008 | CN101229351A Medicine compounds with detoxication uses |
| 07/30/2008 | CN101229349A Medicine for treating senile dementia and preparing method thereof |
| 07/30/2008 | CN101229325A Rhizoma gastrodiae chewable tablet and preparing method thereof |
| 07/30/2008 | CN101229308A Quality control method of liu-wei tonic tablets dual-wavelength fingerprint chromatogram |
| 07/30/2008 | CN101229307A Rehabilitation oral Chinese traditional medicine preparation and preparing process thereof |
| 07/30/2008 | CN101229293A Medicine compounds for treating senile dementia and preparing method thereof |
| 07/30/2008 | CN101229247A Medicine preparation for treating insomnia and preparing method thereof |
| 07/30/2008 | CN101229246A Chinese goldthread colla corii asini decoction oral preparation and preparing method thereof |
| 07/30/2008 | CN101229242A Pain-relieving smelling medicine |
| 07/30/2008 | CN101229240A Nasil powdered medicine for ache |
| 07/30/2008 | CN101229230A Chinese traditional medicine mixture for curing senile dementia |
| 07/30/2008 | CN101229229A Anticancer analgesic percutaneous absorption preparation |
| 07/30/2008 | CN101229210A Applications of herba epimedii total flavone and notoginseng total saponin compounds |
| 07/30/2008 | CN101229203A Valid target of common peganum seed, preparing method and uses of dehydrogenization telepathine monomer |
| 07/30/2008 | CN101229170A The use of mirtazapine for the treatment of sleep disorders |
| 07/30/2008 | CN101229169A Sustained release formulations comprising lamotrigine |
| 07/30/2008 | CN101229153A Application of inulicin on preparating anti-dementia pharmaceutical preparation |
| 07/30/2008 | CN101229132A Nimodipine pulse sustained release mircopill preparation and preparing method thereof |
| 07/30/2008 | CN100406892C Tau-Tau结合的抑制 Tau-Tau binding inhibition |
| 07/30/2008 | CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR |
| 07/30/2008 | CN100406472C Fusion and solubility expression of cobratoxin and acidolysis release and purification of recombinant toxin |
| 07/30/2008 | CN100406467C Method for preparing total saponins from theroots of platycodon grandiflorum utilizing weak polarity macroreticular resin and its use |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
| 07/30/2008 | CN100406448C Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 07/30/2008 | CN100406446C Benzoxazole derivatives and their use as adenosine receptor ligands |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406055C Chinese-medicinal preparation for treating hyposomnia |
| 07/30/2008 | CN100406039C Composition containing an extract of pericarpium zanthoxyli for protecting brain cells and improving memory |
| 07/30/2008 | CN100406012C Hydrobromic acid high tortoiseshell component drip pill and its preparation method |
| 07/30/2008 | CN100406005C Compound and method for therapeutic intervention in preventing diabetic complications |
| 07/29/2008 | US7405323 Invention provides five novel polymorphic forms of modafinil racemate called CRL 40476 form III, CRL 40476 form IV, CRL 40476 form V, CRL 40476 form VI, CRL 40476 form VII; preparing a new solvate of modafinil comprising dissolving in solvent and crystallizing; sleep disorders |
| 07/29/2008 | US7405311 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405241 Administering nitrous oxide or xenon or donors thereof along with oxygen, nitrogen, and/or argon; stroke therapy; neuroprotectants |
| 07/29/2008 | US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405221 2-(4-fluorobenzyloxy)-4-(2,4-dichlorophenyl)-5-(4-chlorophenyl)pyrimidine; antagonists or inverse agonists of the Cannabinoid-1 (CB1) receptor; antidepressant, neuroleptic, anxiolytic, antiinflammatory agent, cognition activator; psychosis, epilepsy, Parkinson's disease, and schizophrenia |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405212 Helix mimetics and composition and methods related thereto |
| 07/29/2008 | US7405049 Elevated concentration of given protein is indicative of sepsis or Alzheimer's disease; procalcitonin biomarker; immunoassay |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | CA2515596C Cannabinoid receptor ligands and uses thereof |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2344893C Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |